Cytosorbents Current Ratio 2007-2019 | CTSO

Cytosorbents current ratio from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cytosorbents Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.03B $0.01B 3.70
2018-12-31 $0.03B $0.01B 4.09
2018-09-30 $0.03B $0.00B 7.03
2018-06-30 $0.03B $0.00B 8.82
2018-03-31 $0.03B $0.00B 6.15
2017-12-31 $0.02B $0.01B 2.64
2017-09-30 $0.02B $0.01B 3.36
2017-06-30 $0.02B $0.01B 3.17
2017-03-31 $0.01B $0.01B 1.02
2016-12-31 $0.01B $0.00B 1.83
2016-09-30 $0.01B $0.01B 1.81
2016-06-30 $0.01B $0.00B 2.82
2016-03-31 $0.01B $0.00B 2.48
2015-12-31 $0.01B $0.00B 3.24
2015-09-30 $0.01B $0.00B 3.36
2015-06-30 $0.01B $0.00B 5.16
2015-03-31 $0.02B $0.01B 2.40
2014-12-31 $0.01B $0.01B 1.69
2014-09-30 $0.01B $0.00B 5.78
2014-06-30 $0.01B $0.00B 3.84
2014-03-31 $0.01B $0.00B 3.59
2013-12-31 $0.00B $0.00B 1.14
2013-09-30 $0.00B $0.00B 1.19
2013-06-30 $0.00B $0.00B 1.23
2013-03-31 $0.00B $0.00B 2.14
2012-12-31 $0.00B $0.00B 1.42
2012-09-30 $0.00B $0.00B 1.38
2012-06-30 $0.00B $0.00B 1.07
2012-03-31 $0.00B $0.00B 1.05
2011-12-31 $0.00B $0.00B 1.11
2011-09-30 $0.00B $0.00B 1.59
2011-06-30 $0.00B $0.00B 2.45
2011-03-31 $0.00B $0.00B 2.01
2010-12-31 $0.00B $0.00B 1.16
2010-09-30 $0.00B $0.00B 0.40
2010-06-30 $0.00B $0.00B 0.55
2010-03-31 $0.00B $0.00B 1.07
2009-12-31 $0.00B $0.00B 2.02
2009-09-30 $0.00B $0.00B 1.10
2009-06-30 $0.00B $0.00B 1.62
2009-03-31 $0.00B $0.00B 2.52
2008-12-31 $0.00B $0.00B 3.16
2008-09-30 $0.00B $0.00B 3.79
2008-06-30 $0.00B $0.00B 3.21
2008-03-31 $0.00B $0.00B 0.20
2007-12-31 $0.00B $0.00B 0.46
2007-09-30 $0.00B $0.00B 1.02
2007-06-30 $0.00B $0.00B 1.00
2007-03-31 $0.00B $0.00B 1.55
2006-12-31 $0.00B $0.00B 2.68
2006-09-30 $0.00B $0.00B 1.51
2006-06-30 $0.01B $0.00B 1.35
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.218B $0.023B
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $134.536B 26.12
Medtronic (MDT) Ireland $119.041B 17.40
Stryker (SYK) United States $69.379B 24.76
Boston Scientific (BSX) United States $52.469B 25.15
Baxter (BAX) United States $38.553B 24.30
Zimmer Biomet Holdings (ZBH) United States $23.583B 15.15
Smith & Nephew SNATS (SNN) United Kingdom $18.443B 0.00
ResMed (RMD) United States $16.221B 30.99
Canopy Growth (CGC) Canada $15.837B 0.00
Bio-Rad Laboratories (BIO) United States $8.801B 46.66
Aurora Cannabis (ACB) Canada $8.731B 86.10
Perrigo (PRGO) Ireland $6.741B 11.40
Hill-Rom Holdings (HRC) United States $6.488B 19.67
Insulet (PODD) United States $6.382B 465.00
GW Pharmaceuticals (GWPH) United Kingdom $5.647B 0.00
Haemonetics (HAE) United States $5.227B 42.87
ICU Medical (ICUI) United States $4.692B 28.00
Hutchison China MediTech (HCM) China $3.596B 0.00
NuVasive (NUVA) United States $3.231B 26.39
Neogen (NEOG) United States $3.044B 49.49
Agios Pharmaceuticals (AGIO) United States $3.015B 0.00
Quidel (QDEL) United States $2.262B 23.47
National Vision Holdings (EYE) United States $2.178B 46.40
Aphria (APHA) $1.690B 0.00
HEXO (HEXO) $1.457B 0.00
Cardiovascular Systems (CSII) United States $1.381B 792.80
Phibro Animal Health (PAHC) United States $1.195B 17.90
AtriCure (ATRC) United States $1.147B 0.00
VAREX IMAGING (VREX) United States $1.067B 22.65
Lantheus Holdings (LNTH) United States $0.962B 25.54
Omeros (OMER) United States $0.942B 0.00
NanoString Technologies (NSTG) United States $0.939B 0.00
MacroGenics (MGNX) United States $0.899B 0.00
PetIQ (PETQ) United States $0.809B 19.64
Eagle Pharmaceuticals (EGRX) United States $0.737B 20.66
Cerus (CERS) United States $0.724B 0.00
TG Therapeutics (TGTX) United States $0.607B 0.00
Surmodics (SRDX) United States $0.536B 77.92
LeMaitre Vascular (LMAT) United States $0.523B 25.33
OraSure Technologies (OSUR) United States $0.521B 23.97
Quanterix (QTRX) United States $0.517B 0.00
Meridian Bioscience (VIVO) United States $0.479B 14.65
Evolus (EOLS) United States $0.479B 0.00
BioLife Solutions (BLFS) United States $0.349B 109.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.333B 0.00
Utah Medical Products (UTMD) United States $0.296B 20.50
Vapotherm (VAPO) United States $0.286B 0.00
Rockwell Medical (RMTI) United States $0.277B 0.00
Zynex (ZYXI) United States $0.244B 25.23
Owens & Minor (OMI) United States $0.224B 4.75
Bovie Medical (APYX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.178B 0.00
Fonar (FONR) United States $0.132B 6.97
Chembio Diagnostics (CEMI) United States $0.126B 0.00
Surface Oncology (SURF) United States $0.112B 0.00
Female Health (VERU) United States $0.110B 0.00
InfuSystems Holdings (INFU) United States $0.097B 0.00
Neurotrope (NTRP) United States $0.092B 0.00
United-Guardian (UG) United States $0.091B 20.10
Insys Therapeutics (INSY) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 20.75
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
GUARDION HEALTH (GHSI) United States $0.041B 0.00
Senestech (SNES) United States $0.038B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
BRAINSWAY LTD (BWAY) Israel $0.027B 0.00
Myomo (MYO) United States $0.016B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 4.89